Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
635
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus – Letters

Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable

Yandong Chenga Department of Endocrinology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, ChinaView further author information
,
Taishun Lib Department of Biomedicine Statistics, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, ChinaView further author information
&
Yi-Hua Zhouc Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8880-0392View further author information
ORCID Icon
Article: 2099163 | Received 19 Jun 2022, Accepted 03 Jul 2022, Published online: 05 Aug 2022

References

  • Finsterer J. Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site. Hum Vaccin Immunother. 2022;in press. doi:10.1080/21645515.2022.2090178.
  • Cheng Y, Li T, Zheng Y, Xu B, Bi Y, Hu Y, Zhou YH. Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2. Hum Vaccin Immunother. 2022;18(5). doi:10.1080/21645515.2022.2064134.
  • Yu BY, Cen LS, Chen T, Yang TH. Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: a case report. World J Clin Cases. 2021;9(27):1–2. doi:10.12998/wjcc.v9.i27.8274.
  • Chen X, Li X, Li H, Li M, Gong S. Ocular adverse events after inactivated COVID-19 vaccination in Xiamen. Vaccines (Basel). 2022;10(3):482. doi:10.3390/vaccines10030482.
  • Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. Jama. 2021;326(1):35–45. doi:10.1001/jama.2021.8565.
  • Tanriover MD, Doganay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213–222. doi:10.1016/S0140-6736(21)01429-X.
  • Fadlyana E, Rusmil K, Tarigan R, Rahmadi AR, Prodjosoewojo S, Sofiatin Y, Khrisna CV, Sari RM, Setyaningsih L, Surachman F, et al. A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: an interim analysis in Indonesia. Vaccine. 2021;39(44):6520–6528. doi:10.1016/j.vaccine.2021.09.052.
  • Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875–884. doi:10.1056/NEJMoa2107715.
  • Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, Asadi-Aliabadi M, Nojomi M. Adverse effects following COVID-19 vaccination in Iran. BMC Infect Dis. 2022;22(1):476. doi:10.1186/s12879-022-07411-5.
  • Baydar O, Özen Ş, Öztürk Şahin B, Köktürk N, Kitapçı MT. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in Turkey: an online survey. Balkan Med J. 2022;39(3):193–198. doi:10.4274/balkanmedj.galenos.2022.2021-11-25.
  • Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, Pokorná A, Klugar M, Riad A. Side effects of COVID-19 inactivated virus vs. adenoviral vector vaccines: experience of Algerian healthcare workers. Front Public Health. 2022;10:896343. doi:10.3389/fpubh.2022.896343.
  • Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, Chui CSL, Wan EYF, Wong CKH, Chan EWY, et al. Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study. Ann Intern Med. 2022;175(3):362–370. doi:10.7326/M21-3700.
  • Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S, Reddy P, et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021;398(10317):2173–2184. doi:10.1016/S0140-6736(21)02000-6.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.